MedPath

Edoxaban Treatment in Routine Clinical Practice for Patients With Atrial Fibrillation in Korea and Taiwan (ETNA-AF-KOR-TWN)

Completed
Conditions
Atrial Fibrillation
Interventions
Registration Number
NCT02951039
Lead Sponsor
Daiichi Sankyo
Brief Summary

In order to understand the risks and benefits of edoxaban use in a real-world clinical setting in the Non valvular Atrial Fibrillation (NVAF) indication, Daiichi-Sankyo proposed this non-interventional study to gain insight into the safety (bleeding, liver adverse events, all-cause mortality and other drug related adverse events) and efficacy of edoxaban use in non-preselected patients with NVAF.

Detailed Description

Edoxaban was approved by the Ministry of Food and Drug Safety (MFDS) in Korea (date: 25th, August 2015) for the reduction in the risk of stroke and systemic embolism in patients with NVAF, treatment of deep vein thrombosis (DVT) and pulmonary embolism. Edoxaban was approved by the Taiwan Food and Drug Administration (TFDA) in Taiwan (date: 24th, February, 2016) for the prevention of stroke and systemic embolism in adult patients with NVAF with one or more risk factors, such as congestive heart failure, hypertension, age at least 75 years, diabetes mellitus, prior stroke or transient ischemic attack (TIA), or treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), following 5 to 10 days of initial therapy with a parenteral anticoagulant.

Real world evidence data of routine clinical practice use of edoxaban up to two years will be collected and evaluated in approximately 2,500 patients, treated by specialized as well as non-specialized physicians in hospital centers.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3008
Inclusion Criteria
  • NVAF-patients treated with edoxaban according to Summary of Product Characteristics (SmPC).
  • Written informed consent for participation in the study (ICF).
  • Not simultaneously participating in any interventional study.
Exclusion Criteria
  • None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
EdoxabanEdoxabanPatients with established NVAF treated with edoxaban according to package information. Physician's prescribing behaviour will not be influenced; patients may only be included after the treating physician has made the clinical decision to prescribe edoxaban.
Primary Outcome Measures
NameTimeMethod
Rate of Participants Experiencing Real-World Safety Data Events within 2 Yearswithin 2 years

Real-world safety data events include bleeding events (including intracranial haemorrhage), adverse events and mortality

Secondary Outcome Measures
NameTimeMethod
Rate of Participants Compliant with Edoxaban Therapy2 years

Categories: Always, Almost Always, Most of the Time, Less than Half the Time, Unknown

Rate of Participants with Patient Relevant Outcomeswithin 2 years

Patient relevant outcomes include Strokes (ischaemic and haemorrhagic) , Systemic Embolic Events (SEE), Transient Ischemic Attack (TIA), Major Adverse Cardiovascular Events (MACE), Venous Thromboembolism (VTE), Acute Coronary Syndrome (ACS), and Hospitalisations related to a cardiovascular (CV) condition.

Trial Locations

Locations (47)

Taipei Veterans General Hospital

πŸ‡¨πŸ‡³

Taipei, Beitou District, Taiwan

Soon Chun Hyang University Hospital Cheonan

πŸ‡°πŸ‡·

Cheonan, Chungcheongnam-do, Korea, Republic of

GangNeung Asan Hospital

πŸ‡°πŸ‡·

Gangneung, Gangwon-do, Korea, Republic of

Yonsei University, Wonju Severance Christian Hospital

πŸ‡°πŸ‡·

Wŏnju, Gangwon-do, Korea, Republic of

Hallym University Medical Center

πŸ‡°πŸ‡·

Anyang-si, Gyeonggi-do, Korea, Republic of

Soon Chun Hyang University Hospital Bucheon

πŸ‡°πŸ‡·

Bucheon-si, Gyeonggi-do, Korea, Republic of

Inje University Ilsan Paik Hospital

πŸ‡°πŸ‡·

Goyang-si, Gyeonggi-do, Korea, Republic of

National Health Insurance Service Ilsan Hospital

πŸ‡°πŸ‡·

Goyang-si, Gyeonggi-do, Korea, Republic of

Ajou University Hospital

πŸ‡°πŸ‡·

Suwon-si, Gyeonggi-do, Korea, Republic of

St. Carollo General Hospital

πŸ‡°πŸ‡·

Suncheon, Jeollanam-do, Korea, Republic of

Samsung Changwon Hospital

πŸ‡°πŸ‡·

Changwŏn, Gyeongsangnam-do, Korea, Republic of

Gyeongsang National University Hospital

πŸ‡°πŸ‡·

Gyeongsang, Jinju-si, Korea, Republic of

Inje Universitiy Busan Paik Hospital

πŸ‡°πŸ‡·

Busan, Korea, Republic of

Inje University Haeundae Paik Hospital

πŸ‡°πŸ‡·

Busan, Korea, Republic of

Keimyung University Dongsan Medical Center

πŸ‡°πŸ‡·

Daegu, Korea, Republic of

Yeongnam University Medical Center (1526)

πŸ‡°πŸ‡·

Daegu, Korea, Republic of

Yeongnam University Medical Center (1533)

πŸ‡°πŸ‡·

Daegu, Korea, Republic of

Chungnam National University Hospital

πŸ‡°πŸ‡·

Daejeon, Korea, Republic of

Chosun University Hospital

πŸ‡°πŸ‡·

Gwangju, Korea, Republic of

Inha University Hospital

πŸ‡°πŸ‡·

Incheon, Korea, Republic of

Gachon University Gil Medical Center

πŸ‡°πŸ‡·

Incheon, Korea, Republic of

Nowon Eulji Medical Center, Eulji University

πŸ‡°πŸ‡·

Seoul, Korea, Republic of

Kyung Hee University Hospital

πŸ‡°πŸ‡·

Seoul, Korea, Republic of

Korea University Anam Hospital

πŸ‡°πŸ‡·

Seoul, Korea, Republic of

Seoul National University Hospital (1512)

πŸ‡°πŸ‡·

Seoul, Korea, Republic of

Seoul National University Hospital (1534)

πŸ‡°πŸ‡·

Seoul, Korea, Republic of

Severance Hospital, Yonsei University Health System

πŸ‡°πŸ‡·

Seoul, Korea, Republic of

Veterans Health Service Medical Center

πŸ‡°πŸ‡·

Seoul, Korea, Republic of

Samsung Medical Center (1520)

πŸ‡°πŸ‡·

Seoul, Korea, Republic of

Samsung Medical Center (1519)

πŸ‡°πŸ‡·

Seoul, Korea, Republic of

Korea University Guro Hospital

πŸ‡°πŸ‡·

Seoul, Korea, Republic of

Chang Gung Memorial Hospital, Linko

πŸ‡¨πŸ‡³

Taoyuan, Guishan District, Taiwan

Tri-Service General Hospital

πŸ‡¨πŸ‡³

Taipei, Neihu District, Taiwan

Chang Gung Memorial Hospital, KaoHsiung

πŸ‡¨πŸ‡³

Kaohsiung, Niaosong District, Taiwan

National Taiwan University Hospital

πŸ‡¨πŸ‡³

Taipei, Zhongzheng District, Taiwan

Taichung Veterans General Hospitial

πŸ‡¨πŸ‡³

Kaohsiung, Niaosong District, Taiwan

Cheng Hsin General Hospital

πŸ‡¨πŸ‡³

Taipei, Pai-Tou, Taiwan

KaoHsiung Veterans General Hospital

πŸ‡¨πŸ‡³

Kaohsiung, Zuoying District, Taiwan

Chung Shan Medical University Hospitial

πŸ‡¨πŸ‡³

Taichung, Taiwan

China Medical University Hospital

πŸ‡¨πŸ‡³

Taichung, Taiwan

Seoul National University Bundang Hospital

πŸ‡°πŸ‡·

Seongnam-si, Gyeonggi-do, Korea, Republic of

Dong A University Hospital

πŸ‡°πŸ‡·

Busan, Korea, Republic of

Hanyang University Seoul Hospital

πŸ‡°πŸ‡·

Seoul, Korea, Republic of

Seoul Metropolitan Government Seoul National University Boramae Medical Center

πŸ‡°πŸ‡·

Seoul, Korea, Republic of

Hallym University, Kangnam Sacred Heart Hospital

πŸ‡°πŸ‡·

Seoul, Korea, Republic of

Chonnam National University Hospital

πŸ‡°πŸ‡·

Gwangju, Korea, Republic of

Gangnam Severance Hospital, Yonsei University Health System

πŸ‡°πŸ‡·

Seoul, Korea, Republic of

Β© Copyright 2025. All Rights Reserved by MedPath